Outcomes of Older Adults and Frail Patients Receiving Idecabtagene Vicleucel: A CIBMTR Study.
Akhtar OS, Oloyede T, Brazauskas R, Afrough A, Hashmi H, Sidana S, Ahmed N, Bye M, Hansen DK, Ferreri CJ, Dhakal B, Dhanda DS, Harrison MJ, Kitali A, Landau HJ, Mirza AS, Patel J, Patwardhan P, Qazilbash MH, Patel KK, Nishihori T, Ganguly S, Gowda L, Anderson LD Jr, Pasquini MC, Usmani SZ, Freeman CL.
Akhtar OS, et al. Among authors: anderson ld jr.
Blood Adv. 2024 Dec 30:bloodadvances.2024014970. doi: 10.1182/bloodadvances.2024014970. Online ahead of print.
Blood Adv. 2024.
PMID: 39786391